🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Screening

"Xijiang Project" Screening Cohort for NPC NCT06787456n/a1 site📍 Zhuhai Ming-Yuan Chen · Tests: EBV antibodies test, EBV DNA test, epidemiological information survey, Clinical examinations for high-risk participants… Emphysema Research Registry and Biosample Repository NCT00307281n/a1 site📍 Pittsburgh University of Pittsburgh Effectiveness of Best Care Practices in Acute Stroke in Conventional Hospitalization (BEST CARE ICTUS_HC) NCT07627399NA4 sites📍 Antequera📍 Marbella📍 Ronda University of Malaga · Tests: BEST CARE ICTUS_HC BUNDLE Combined Effects of Calisthenics and Plyometric to Reduce Risk of Musculoskeletal Injuries Among School Going Children NCT06732687NA1 site📍 Rawalpindi Riphah International University · Tests: Calisthenics, Plyometrics, Combined( Calisthenics+ Plyometrics) Predicting Toxicity in Elderly Patients With Head and Neck Cancer NCT06344208n/a1 site📍 Milan European Institute of Oncology Pancreatic Cancer Screening Through the Detection of Elastase-1 Combined With Other Examinations NCT06041009n/a1 site📍 Jinan Qilu Hospital of Shandong University · Tests: Pancreatic elastase-1 in blood serum DEPRECAP: Lung Cancer Screening Programme by LDCT for Patients With COPD or Emphysema. NCT06690385n/a2 sites📍 Madrid📍 Madrid Instituto de Investigación Sanitaria de la Fundación Jiméne… The Development of MASLD Among Survivors of Breast or Colorectal Cancer NCT07280143n/a1 site📍 Bern University of Bern Multimodality Imaging in the Screening, Diagnosis and Risk StratifictiON of HFpEF NCT04603404n/a1 site📍 Beijing Chinese Academy of Medical Sciences, Fuwai Hospital Rheumatoid Arthritis Remission Screening and Prospective Surveillance NCT07571993n/a1 site📍 Pavia Fondazione IRCCS Policlinico San Matteo di Pavia Missed Opportunities for HIV Screening in General Practice NCT07303114n/a1 site📍 Strasbourg University Hospital, Strasbourg, France Clinical Performance of Medical Device Software "Lipidica 1.0" for Processing Data Generated by Lipidomic Analysis in Pancreatic Cancer Screening NCT06549725NA16 sites📍 Prague📍 Brno📍 Brno Lipidica, a.s. · Tests: software Lipidica, endoscopic ultrasonography, magnetic resonance, laboratory examination, computed tomography Biomarkers and Imaging Markers for ICH NCT06462274n/a1 site📍 Chongqing Southwest Hospital, China · Tests: body sample collection and imaging scan Evaluation of Cell Changes in Blood and Tissue in Cancers of the Lung, Esophagus and Lung Lining NCT00242723n/a1 site📍 Bethesda National Cancer Institute (NCI) Routine Shallow-coverage Whole Genome Sequencing Testing of Liquid-based Cervical Smears for the Early Diagnosis of Ovarian Cancer NCT07821879n/a1 site📍 Toulouse Institut Claudius Regaud Screening of Healthy Volunteers for Investigational Antimalarial Drugs, Malaria Vaccines, and Controlled Human Malaria Challenge NCT02639299n/a1 site📍 Bethesda National Institute of Allergy and Infectious Diseases (NIAI… The ORIGIN-FH Study NCT07470723NA1 site📍 Madison University of Wisconsin, Madison · Tests: Screening for FH Screening for Biomarkers of Osteonecrosis of the Femoral Head NCT07545616n/a1 site📍 Xinxiang The First Affiliated Hospital of Xinxiang Medical College Utility of Biparametric MRI (Magnetic Resonance Imaging) as a Screening Tool for Prostate Cancer in a High-Risk Cohort NCT05384535NA1 site📍 Lake Success Northwell Health · Tests: Bi-parametric MRI Application of CfDNA Methylation Detection in Auxiliary Diagnosis of Breast Cancer NCT06876610n/a1 site📍 Beijing Geneplus-Beijing Co. Ltd. Implementation and Evaluation of a Fear of Cancer Recurrence Screening, Referral and Management Program NCT06181344NA2 sites📍 Hong Kong📍 Hong Kong The University of Hong Kong · Tests: FCR screening and referral program Cleansing Options in Out-Patient Setting to Improve Tolerance (COOP SIT) Trial NCT07215000Phase 41 site📍 Atlanta Morehouse School of Medicine · Tests: Golytely, Sulfave, Sutab Method Comparison of Intelligent Fingerprinting Drug Screening System NCT07650136n/a1 site📍 Marlton Intelligent Bio Solutions Inc. Assessment of the Effectiveness of the Metabolomic Approach in Screening for Endometrial Cancer NCT06893861n/a1 site📍 Naples National Cancer Institute, Naples · Tests: Metabolomic profiling Evaluation of a Diagnostic Test to Identify the Best Drugs for Treatment of Metastatic Colorectal Cancer NCT07171554NA1 site📍 Lørenskog Oncosyne AS · Tests: µCAN drug screen test, Standard-of-Care Therapy Lucid Registry Study NCT05965999n/a1 site📍 Lake Forest Lucid Diagnostics, Inc. · Tests: EsoCheck®, EsoGuard® Developing and Implementing HPV SCREENED NCT07657104NA2 sites📍 New Brunswick📍 Newark Rutgers, The State University of New Jersey · Tests: HPV Self-collection in the ED Increasing the Coverage of Severe Acute Malnutrition (SAM) Treatment in Ethiopia NCT06380504NA1 site📍 Jimma International Food Policy Research Institute · Tests: R-SWITCH integrated intervention package INNODIA Family & Friends Early-Stage T1D Detection Protocol NCT07118098n/a21 sites📍 Vienna📍 Leuven📍 Prague INNODIA iVZW Singula Phase 0.1 Primary Care Pilot NCT07834684n/a2 sites📍 Brentwood📍 Mount Kisco Singula Health, Inc.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy